척수자극요법 세계 시장 규모는 2022년 29억 달러로 평가되며, 2023년 31억 3,000만 달러에서 2031년 57억 달러로 성장하여 예측 기간(2024-2031년) 동안 7.8%의 CAGR로 성장할 것으로 예상됩니다.
척수 자극기(SCS)는 등 기둥 자극기라고도 불리며, 만성 통증 관리에 효과적인 신경 조절 장치로 전 세계 시장에서 큰 호응을 얻고 있습니다. 이 이식형 기기는 통증 신호를 차단하여 척수, 허리 및 사지 통증으로 고통받는 사람들, 특히 기존의 약물 및 치료법이 효과가 없는 경우 도움을 줄 수 있습니다. 최근 기술 발전과 더불어 SCS 수술에 대한 새로운 법적 가이드라인과 최소침습적 치료에 대한 선호도가 높아지면서 시장 성장을 더욱 촉진하고 있습니다. 또한, 좌식 생활로 인한 만성 통증의 증가도 신경자극치료에 대한 수요 증가에 기여하고 있습니다. 이러한 요인들이 복합적으로 작용하여 SCS 시장은 가까운 시일 내에 비약적인 성장과 함께 더 큰 기회를 맞이할 것으로 보입니다.
Global Spinal Cord Stimulation Market size was valued at USD 2.9 billion in 2022 and is poised to grow from USD 3.13 billion in 2023 to USD 5.7 billion by 2031, growing at a CAGR of 7.8% during the forecast period (2024-2031).
The spinal cord stimulator (SCS), also known as the dorsal column stimulator, is gaining significant traction in the global market as an effective neuromodulation device for chronic pain management. This implanted tool disrupts pain signals, aiding individuals suffering from spinal, back, or limb pain, particularly when traditional medications and therapies fail. Recent advancements in technology, alongside new legislative guidelines for SCS operations and the rising preference for minimally invasive treatments, have further fueled market growth. The increasing prevalence of chronic pain, largely attributable to sedentary lifestyles, is also contributing to the surging demand for neurostimulation therapies. This combination of factors positions the SCS market for expansive growth and greater opportunities in the near future.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spinal Cord Stimulation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Spinal Cord Stimulation Market Segmental Analysis
Global Spinal Cord Stimulation Market is segmented by indication, product, end user and region. Based on indication, the market is segmented into failed back surgery syndrome, complex regional pain syndrome, degenerative disc disease and others. Based on product, the market is segmented into rechargeable devices and non-rechargeable devices. Based on end user, the market is segmented into hospitals, ambulatory surgical centers and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Spinal Cord Stimulation Market
The Global Spinal Cord Stimulation market is being propelled forward by continuous technological advancements and supportive government recommendations. Manufacturers are focusing on research to produce smaller spinal cord stimulators, exemplified by Stimwave LCC's Freedom SCS system, which is about 5% smaller than current Implantable Pulse Generators (IPGs). This reduction in size, along with improvements in impulse generation, significantly contributes to the market's growth. Furthermore, various government associations are developing guidelines for spinal cord stimulation therapy to treat chronic pain and other conditions. Notably, the National Institute for Health and Care Excellence has provided recommendations for the Senza SCS system, which delivers HF10 therapy for neuropathic pain, fostering increased market activity through these favorable endorsements.
Restraints in the Global Spinal Cord Stimulation Market
The Global Spinal Cord Stimulation market faces several significant restraints that impede its growth. One of the primary challenges is the high cost associated with spinal cord stimulator implantation, which ranges from $21,000 to $58,000. The financial burden varies depending on the patient's insurance status, whether private or public, or if they are paying out-of-pocket. Moreover, ongoing maintenance expenses-including hardware costs, salaries of healthcare providers, pulse generator replacements, and hospitalization fees-add to the overall financial strain on patients. Additionally, the limited availability of healthcare equipment in remote areas restricts access to treatment, forcing local populations to depend on larger towns for essential medical services.
Market Trends of the Global Spinal Cord Stimulation Market
The Global Spinal Cord Stimulation (SCS) market is experiencing a significant upward trend due to increasing government initiatives aimed at reducing opioid dependence. With rising concerns about opioid misuse, alternative therapies that provide effective pain management without the addictive risks of opioids are gaining traction. This shift has prompted manufacturers such as Medtronic, Abbott, and Boston Scientific to expedite the development and approval of innovative SCS devices, evidenced by over 200 submissions to the FDA for rapid approval. As awareness and demand for these non-opioid solutions continue to rise, the SCS market is poised for substantial growth, presenting lucrative opportunities for stakeholders.